REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/17/2025
Back to search
Official data from USPTO
LOKAVANT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LOKAVANT
ST13
US500000088703456Class
35, 42
Filing
88703456
Registration
6198496
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
11/18/2025
Trademark type
Word
Nice classes
35, 42
Filing date
11/22/2019
Registration date
11/17/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/17/2020
Last transaction
11/18/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
03
Owner location
NEW YORK, NY
Examiner
KETCHUM,BRENDAN J
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
LOKAVANT, INC.
Roivant Sciences GmbH
Representatives
Allison Strickland Ricketts FROSS ZELNICK LEHRMAN & ZISSU, P.C.
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Advertising services; business management; business administration services; providing office functions; business research services; business information services; market research; provision of market research information; data processing services; analysis of business data; artificial intelligence and machine learning statistical analysisconsultancy and reporting for pharmaceutical and biomedical research for business purposes; business analysis and statistical analysis of healthcare datapharmaceuticalsbiomedical researchfor clinical trial and post-market data for business purposes; systematization and compilation of data in computer databasesin particular compilation of information into computer databases for research and analysis purposes in the field of healthcarepharmaceuticalsbiomedicinepharmaceutical and biomedical research and developmentclinical trials and post-market data; professional business analysis and consultancy and statistical analysis in the fields of healthcarepharmaceuticalsbiomedicineclinical trialsepidemiological researchpharmacoepidemiological researchpost-market trials and research evaluating epidemiological outcomes
Class 42
Scientific and technological servicesmedical researchscientific research and analysis in the field of pharmaceuticals and biomedicine; analysis of technical data by computerscomputer modeling services; pharmaceuticalbiomedicalbiological therapeutic research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical and biopharmaceutical research and development; providing scientific research information in the field of pharmaceuticalsbiomedicineclinical trials and post-market trials; cloud computing featuring software for compilingaccessingcontrollingmanaging and providing updated scientificpharmaceuticalmedical and clinical informationnews of general interest; cloud computing featuring software for conducting scientific research and analysis in the fields of public healthhealthcarepharmaceutical and biomedical researchclinical trial data and data from examinations carried out after the introduction of medicines on the market; cloud computing featuring software for providinganalyzing and generating reportsfor data processingfor the capturecollectionconversionanalysiscommunicationprocessingreceivingrecordingstorage and/or transmission of dataimages and informationfor the conversionanalysisprocessingstorage and transmission of artificial intelligencefor database integrationfor creating searchable databases of information and datafor analytics in the fields of healthcarepharmaceuticalsbiomedicinepharmaceutical and biomedical research and developmentfor clinical trial and post-market trial datafor managing and analyzing clinical trial and clinical research workflowfor use in collecting and managing data in the field of biomedical researchfor biomedical and clinical research servicesfor database management software for use in biomedical and clinical and medical research; providing temporary use of online non-downloadable computer software featuring electronic computer databases of pharmaceuticalsbiomedicinepharmaceutical and biopharmaceutical research and developmentmedical informationclinical trial and post-market trial data; providing temporary use of online non-downloadable computer software for research in the field of pharmaceuticals and biopharmaceuticals; providing temporary use of online non-downloadable computer software for compilingaccessingcontrollingmanaging and providing updated scientificpharmaceuticalmedical and clinical informationnews information of general interest; providing temporary use of non-downloadable software applications accessible via a web site for data analyticsfinancial analytics and risk management for use in the fields of pharmaceutical and biomedical research and developmentclinical trialsthe provision of medical and healthcare services; application service provider featuring software for collectingprocessingstoringextractinganalyzing and transmitting clinical research data
Publications
History of USPTO decisions and trademark events.
21 publications found
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/09/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
11/17/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/01/2020
PUBO
PUBLISHED FOR OPPOSITION
09/01/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/12/2020
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
07/21/2020
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
07/17/2020
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
07/10/2020
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
06/26/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/24/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/23/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/22/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/22/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/20/2019
GNRT
NON-FINAL ACTION E-MAILED
12/20/2019
CNRT
NON-FINAL ACTION WRITTEN
12/20/2019
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
12/18/2019
DOCK
ASSIGNED TO EXAMINER
12/18/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/02/2019
NWAP
NEW APPLICATION ENTERED
11/26/2019
Continuous trademark protection
Get notified about every new filing that threatens LOKAVANT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.